112 related articles for article (PubMed ID: 38079527)
1. Tumor Cell Lysate-Based Multifunctional Nanoparticles Facilitate Enhanced mRNA Delivery and Immune Stimulation for Melanoma Gene Therapy.
Huang J; Wang K; Wu S; Zhang J; Chen X; Lei S; Wu J; Men K; Duan X
Mol Pharm; 2024 Jan; 21(1):267-282. PubMed ID: 38079527
[TBL] [Abstract][Full Text] [Related]
2. Efficient Colon Cancer Immunogene Therapy Through Co-Delivery of IL-22BP mRNA and Tumor Cell Lysate by CLSV Nanoparticles.
Huang J; Wang K; Fu X; Zhu M; Chen X; Gao Y; Ma P; Duan X; Men K
Int J Nanomedicine; 2023; 18():8059-8075. PubMed ID: 38164262
[TBL] [Abstract][Full Text] [Related]
3. Functionalized DMP-039 Hybrid Nanoparticle as a Novel mRNA Vector for Efficient Cancer Suicide Gene Therapy.
Gao Y; Men K; Pan C; Li J; Wu J; Chen X; Lei S; Gao X; Duan X
Int J Nanomedicine; 2021; 16():5211-5232. PubMed ID: 34366664
[TBL] [Abstract][Full Text] [Related]
4. Local and Systemic Delivery of the BimS Gene Nano-Complex for Efficient Oral Squamous Cell Carcinoma Therapy.
Ma P; Li J; Gao Y; Wu J; Men K; Li C; Men Y; Duan X
Int J Nanomedicine; 2022; 17():2925-2941. PubMed ID: 35814613
[TBL] [Abstract][Full Text] [Related]
5. Single Micelle Vectors based on Lipid/Block Copolymer Compositions as mRNA Formulations for Efficient Cancer Immunogene Therapy.
Li J; Men K; Gao Y; Wu J; Lei S; Yang Y; Pan H
Mol Pharm; 2021 Nov; 18(11):4029-4045. PubMed ID: 34559545
[TBL] [Abstract][Full Text] [Related]
6. Targeted Nanotherapeutics Using LACTB Gene Therapy Against Melanoma.
Liu J; Yang L; Yuan X; Xiong M; Zhu J; Wu W; Ren M; Long J; Xu X; Gou M
Int J Nanomedicine; 2021; 16():7697-7709. PubMed ID: 34819728
[TBL] [Abstract][Full Text] [Related]
7. Prolongation of life in rats with malignant glioma by intranasal siRNA/drug codelivery to the brain with cell-penetrating peptide-modified micelles.
Kanazawa T; Morisaki K; Suzuki S; Takashima Y
Mol Pharm; 2014 May; 11(5):1471-8. PubMed ID: 24708261
[TBL] [Abstract][Full Text] [Related]
8. Development and screening of brain-targeted lipid-based nanoparticles with enhanced cell penetration and gene delivery properties.
Dos Santos Rodrigues B; Lakkadwala S; Kanekiyo T; Singh J
Int J Nanomedicine; 2019; 14():6497-6517. PubMed ID: 31616141
[TBL] [Abstract][Full Text] [Related]
9. Modifying plasmid-loaded HSA-nanoparticles with cell penetrating peptides - Cellular uptake and enhanced gene delivery.
Mesken J; Iltzsche A; Mulac D; Langer K
Int J Pharm; 2017 Apr; 522(1-2):198-209. PubMed ID: 28279738
[TBL] [Abstract][Full Text] [Related]
10. Coated microneedles mediated intradermal delivery of octaarginine/BRAF siRNA nanocomplexes for anti-melanoma treatment.
Ruan W; Zhai Y; Yu K; Wu C; Xu Y
Int J Pharm; 2018 Dec; 553(1-2):298-309. PubMed ID: 30347273
[TBL] [Abstract][Full Text] [Related]
11. Suppression of tumor growth by systemic delivery of anti-VEGF siRNA with cell-penetrating peptide-modified MPEG-PCL nanomicelles.
Kanazawa T; Sugawara K; Tanaka K; Horiuchi S; Takashima Y; Okada H
Eur J Pharm Biopharm; 2012 Aug; 81(3):470-7. PubMed ID: 22579732
[TBL] [Abstract][Full Text] [Related]
12. Development of cell-penetrating peptide-modified MPEG-PCL diblock copolymeric nanoparticles for systemic gene delivery.
Tanaka K; Kanazawa T; Shibata Y; Suda Y; Fukuda T; Takashima Y; Okada H
Int J Pharm; 2010 Aug; 396(1-2):229-38. PubMed ID: 20600726
[TBL] [Abstract][Full Text] [Related]
13. Spatiotemporally controllable diphtheria toxin expression using a light-switchable transgene system combining multifunctional nanoparticle delivery system for targeted melanoma therapy.
He M; Wang Y; Chen X; Zhao Y; Lou K; Wang Y; Huang L; Hou X; Xu J; Cai X; Cheng Y; Lan M; Yang Y; Gao F
J Control Release; 2020 Mar; 319():1-14. PubMed ID: 31838205
[TBL] [Abstract][Full Text] [Related]
14. Modification of calcium carbonate based gene and drug delivery systems by a cell-penetrating peptide.
Zhao D; Zhuo RX; Cheng SX
Mol Biosyst; 2012 Oct; 8(12):3288-94. PubMed ID: 23086311
[TBL] [Abstract][Full Text] [Related]
15. A novel Granzyme B nanoparticle delivery system simulates immune cell functions for suppression of solid tumors.
Qian X; Shi Z; Qi H; Zhao M; Huang K; Han D; Zhou J; Liu C; Liu Y; Lu Y; Yuan X; Zhao J; Kang C
Theranostics; 2019; 9(25):7616-7627. PubMed ID: 31695790
[TBL] [Abstract][Full Text] [Related]
16. Cell-penetrating Peptide-modified Targeted Drug-loaded Phase-transformation Lipid Nanoparticles Combined with Low-intensity Focused Ultrasound for Precision Theranostics against Hepatocellular Carcinoma.
Zhao H; Wu M; Zhu L; Tian Y; Wu M; Li Y; Deng L; Jiang W; Shen W; Wang Z; Mei Z; Li P; Ran H; Zhou Z; Ren J
Theranostics; 2018; 8(7):1892-1910. PubMed ID: 29556363
[No Abstract] [Full Text] [Related]
17. The effect of dexamethasone/cell-penetrating peptide nanoparticles on gene delivery for inner ear therapy.
Yoon JY; Yang KJ; Park SN; Kim DK; Kim JD
Int J Nanomedicine; 2016; 11():6123-6134. PubMed ID: 27895484
[TBL] [Abstract][Full Text] [Related]
18. Degradable polyethylenimine derivate coupled to a bifunctional peptide R13 as a new gene-delivery vector.
Liu K; Wang X; Fan W; Zhu Q; Yang J; Gao J; Gao S
Int J Nanomedicine; 2012; 7():1149-62. PubMed ID: 22412301
[TBL] [Abstract][Full Text] [Related]
19. Multifunctional nanoparticles co-delivering Trp2 peptide and CpG adjuvant induce potent cytotoxic T-lymphocyte response against melanoma and its lung metastasis.
Xu Z; Ramishetti S; Tseng YC; Guo S; Wang Y; Huang L
J Control Release; 2013 Nov; 172(1):259-265. PubMed ID: 24004885
[TBL] [Abstract][Full Text] [Related]
20. The influence of the penetrating peptide iRGD on the effect of paclitaxel-loaded MT1-AF7p-conjugated nanoparticles on glioma cells.
Gu G; Gao X; Hu Q; Kang T; Liu Z; Jiang M; Miao D; Song Q; Yao L; Tu Y; Pang Z; Chen H; Jiang X; Chen J
Biomaterials; 2013 Jul; 34(21):5138-48. PubMed ID: 23582684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
